The market value of Ropharma Braşov (IAFR) retail pharmacynetwork, owed by businessman Mihai Miron, has over the past fourmonths climbed by 53m euros on the Stock Exchange, with the companycurrently valued at 94.1m euros. Thus, the value of the 88% stakein Ropharma Miron owns directly and indirectly has risen by 47meuros.
The drug distributor, which announced it moved to the tier 1 ofthe Stock Exchange, has thus become the biggest listedpharmaceutical company, leaving far behind companies that arebetter known on the market, such as Zentiva Bucureşti (SCD), whichhas a 77m-euro capitalisation, Antibiotice Iaşi (ATB) or BiofarmBucureşti (BIO).
"I've worked in the pharmaceutical industry ever since the fall ofcommunism and I am a little dissatisfied the pharmaceutical sector,a star on international stock markets, has had a low profile in ourcountry. I hope that by listing Ropharma on the first tier of theStock Exchange we should stir investors' interest in this field,"stated Mihai Miron.
Pentru alte știri, analize, articole și informații din business în timp real urmărește Ziarul Financiar pe WhatsApp Channels
